U.S. markets closed


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.4800-0.0160 (-3.23%)
At close: 1:33PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.4960
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.4800 - 0.4800
52 Week Range0.2320 - 0.5280
Avg. Volume810
Market Cap19.812M
Beta (5Y Monthly)0.70
PE Ratio (TTM)12.00
EPS (TTM)0.0400
Earnings DateMar 31, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Biorem Reports $2.1 million Earnings for Fiscal 2020
    PR Newswire

    Biorem Reports $2.1 million Earnings for Fiscal 2020

    BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results for the three and twelve-month periods ended December 31, 2020. Biorem's complete fiscal 2020 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com).

  • TSX Venture Exchange Stock Maintenance Bulletins
    CNW Group

    TSX Venture Exchange Stock Maintenance Bulletins

    VANCOUVER, BC, March 19, 2021 /CNW/ - TSX VENTURE COMPANIESMINEWORX TECHNOLOGIES LTD. ("MWX") BULLETIN TYPE: Consolidation BULLETIN DATE: March 19, 2021 TSX Venture Tier 2 CompanyPursuant to a special resolution passed by shareholders on March 2, 2021, the Company has consolidated its capital on a (2) old for (1) new basis.

  • GuruFocus.com

    Bye, Orem

    Shares remained range-bound for years while the company continued to deliver reasonable returns on its capital